Article Information
History
- September 21, 2021.
Article Versions
- Version 1 (February 2, 2021 - 17:54).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Febe van Maldegem1,7,8,*,
- Karishma Valand1,8,
- Megan Cole1,
- Harshil Patel2,
- Mihaela Angelova3,
- Sareena Rana1,4,
- Emma Colliver3,
- Katey Enfield3,
- Nourdine Bah2,
- Gavin Kelly2,
- Victoria Siu Kwan Tsang1,
- Edurne Mugarza1,
- Christopher Moore1,
- Philip Hobson5,
- Dina Levi5,
- Miriam Molina-Arcas1,
- Charles Swanton3,6 and
- Julian Downward1,4,*
- 1Oncogene Biology Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK
- 2Bioinformatics and Biostatistics Science Technology Platform, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK
- 3Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK
- 4Lung Cancer Group, Division of Molecular Pathology, Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK
- 5Flow Cytometry Science Technology Platform, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK
- 6Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6DD, UK
- 7Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Location VUMC, De Boelelaan 1108, 1081HZ Amsterdam, The Netherlands
- ↵*Correspondence: f.vanmaldegem{at}amsterdamumc.nl, julian.downward{at}crick.ac.uk
↵8 These authors contributed equally: Febe van Maldegem, Karishma Valand